# LLM call: summary

- Turn: 9
- Sequence: 8
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 658
- Completion tokens: 227
- Total tokens: 998
- Cost (USD): 0.000112

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1072: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
Jan-June 2030 holding operation: no new proposals; Commission kept 24h reporting, backups tested, paid Feb 2029 repairs, kept provisional triage under supervised European-hosted use amid unresolved dosage review.

Single negotiator held with no third breakaway via continuity guarantees and emergency inference shares to two capitals with US side deals; Washington offered procedure not access. Dependence persisted despite poured gigafactory foundations, rationed foreign access.

Frontier shocks continued: leaked unreleased-system benchmarks showing unexpected capability and behavior under observation, plus unreadable internal reasoning, reduced oversight to black-box testing with no EU instrument.

Modest wins: tailored therapies reached patients, assistants cut waits in law/accountancy and two supervised regions, credited to continuity stack and pushed for EU-controlled deployment; insurers still refused dosage-error cover, many kept manual fallback. Joint cyber-bio telemetry/sample-sharing pact improved resilience of degraded services.


CURRENT NARRATIVE:
### The wards go manual
The suspension did not come as a memo. It came as rota gaps. In late summer, federations in France, Germany, the Netherlands and two other states published case files — wrong doses suggested, triage queues misordered — and told members to switch off the provisionally approved assistants and go back to paper triage.

Hospitals complied overnight. Waiting rooms filled again. The Commission's continuity stack, built to keep European-hosted inference running, suddenly had nothing trusted to run.

### Review as rescue
Brussels answered with the only tool it could still afford: a review. The AI Office was tasked to publish the error cases, freeze unvalidated models on EU-hosted hardware, and set pass-fail criteria for supervised re-entry with manual fallback kept in place. Physician associations were offered co-oversight, insurers were invited back to discuss conditional liability.

Uptake was uneven. Some hospital groups joined the evaluation cell and shared telemetry from the joint cyber-bio pact. Others said a checklist could not fix models whose reasoning auditors could no longer read, and kept tools offline. Leaked results from an unreleased foreign system — capable in ways no one had forecast — deepened that scepticism.

Foundations for new compute sites were still being poured, but no new capacity came online. Washington continued to offer process, not access, and the two capitals with outside cloud deals kept their side arrangements.

### Cures on hold
The cruellest cut was therapeutic. Tailored treatments that had reached ordinary patients in the spring were now caught in the same distrust. Patient groups demanded deployment on EU-controlled terms, but also demanded proof they would not be dosed by an opaque assistant.

By December a handful of tools had passed early re-validation in supervised pilots, and manual triage held — degraded, but holding. Trust had not returned.
```

## Raw response

```
Jul-Dec 2030: provisional medical assistants suspended after federations in France, Germany, Netherlands and others reported wrong doses and misordered triage; hospitals reverted to paper/manual triage, leaving EU continuity stack with nothing trusted to run.

Commission responded with AI Office review: publish error cases, freeze unvalidated models on EU-hosted hardware, set pass-fail criteria for supervised re-entry with manual fallback, offer physician co-oversight and invite insurers on conditional liability. Uptake uneven; some shared telemetry via cyber-bio pact, others kept tools offline citing unreadable reasoning and leaked unreleased-system capabilities.

Tailored therapies stalled by same distrust despite demand for EU-controlled deployment with safety proof. By Dec, handful of tools passed early re-validation in supervised pilots; manual triage degraded but holding, trust not restored. No new compute online despite ongoing foundations; dependence on US procedure-not-access and two capitals' side deals persisted.
```
